The global Aptamers Market Growth Accelerated by Increased Adoption in Diagnostics and Therapeutics


Aptamers are single-stranded oligonucleotides typically made of DNA or RNA that undergo an in vitro selection process and act as ligands that bind to many targets with high affinity and specificity. They find widespread applications in diagnostics, research, and therapeutics. Aptamers offer advantages over antibodies such as easier production, low immunogenicity, better stability, and lower cost. The growing need for more affordable and effective diagnostics and therapeutics is driving the demand for aptamers.


The global Aptamers Market is estimated to be valued at US$ 6265.49 Mn in 2023 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Increasing R&D investments and clinical trials for aptamer-based therapeutic applications is one of the key trends fueling the growth of the aptamers market. Several biopharmaceutical companies are engaged in developing novel aptamer-based drugs and therapeutics for disease conditions such as macular degeneration, cancer, and blood coagulation disorders. For instance, MacuSight, a clinical-stage ophthalmology company, is developing an aptamer-based therapy (APX001) for the treatment of neovascular age-related macular degeneration (nAMD). Successful development and commercialization of such aptamer-based therapies will further augment the adoption of aptamers in the years to come.


Segment Analysis
Content: The global aptamers market size is segmented into type, technology, application and end use. By type, DNA aptamers dominated the market and accounted for the largest market share in 2023. DNA aptamers are stable, easy to produce and less expensive than other aptamers like RNA. By technology, SELEX (Systematic Evolution of Ligands by EXponential enrichment) is the dominating technology as it is cost effective, robust and widely used to develop aptamers against various targets.

Key Takeaways

The global Aptamers Market is estimated to be valued at US$ 6265.49 Mn in 2023 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023 to 2030.


Regional analysis related content comprises:
North America dominated the aptamers market in 2023. Presence of major pharmaceutical companies and ongoing research in developing new aptamers-based assays and diagnostics are fueling market growth in the region. Asia Pacific is expected to witness fastest growth during the forecast period. Growth in this region can be attributed to increasing investment in life science research, growing biotechnology industry and rising healthcare spending.

Key players related content comprises:
Key players operating in the Aptamers market are ContiTech Australia Pty. Ltd., Endless Belt Service Pty Ltd., Fenner Dunlop Australia Pty Ltd, Flexible Steel Lacing Company (Flexco), Kinder Australia Pty Ltd., Mato GmbH & Co. KG., Minprovise Pty Ltd, Nepean Engineering & Innovation Pty Ltd., Reliable Conveyor Belt Pty. Ltd., Rema Tip Top Australia, Forbo Siegling PTY. Ltd., and others.

Comments

Popular posts from this blog

The global Ion Exchange Membrane Market Growth Accelerated by Increasing Industrialization and Urbanization

Healthcare IT (HCIT) is fastest growing segment fueling the growth of Drug for Abuse Testing Devices Market

Electric Powertrain Market Growth Accelerated by Adoption of Stringent Emission Regulations